1. Introduction
Fatty acids
(FAs) serve as an energy source and play a crucial role in multiple biological processes, including cellular function, metabolic regulation, and hormone responsiveness [
1]. FAs constitute a diverse family of compounds characterized by a carboxylic acid group
(COOH) at one end (alpha) and a methyl group
(CH3) at the opposite end (omega) [
2]. FAs are classified based on the number of double bonds in their structure into saturated (no double bonds), monounsaturated (one double bond), and polyunsaturated FAs (
PUFAs; two or more double bonds) [
3]. PUFAs are further classified as omega-6 and omega-3, depending on the location of the first double bond at the sixth or third carbon counting from the omega end, respectively [
3,
4]. In typical U.S. dairy cattle diets, linoleic acid (
LA; C18:2 n-6) and α-linolenic acid (
ALA; C18:3 n-3) are the predominant dietary sources of omega-6 and omega-3 fatty acids and represent the major PUFAs present in plant-based forages and concentrates.
Total mixed rations
(TMRs) fed to dairy cattle in modern U.S. operations often present an imbalance between omega-6 and omega-3 FAs since several components in the diet are high in omega-6, and just a few contain omega-3 FAs [
5]. Since omega-6 and -3 are associated with pro-inflammatory and anti-inflammatory pathways, respectively [
6], this imbalance can contribute to an increased production of pro-inflammatory compounds. In contrast, an omega-6 to omega-3 balance in dairy cattle diets is linked to benefits for health and reproductive performance [
5]. For instance, increasing dietary ALA content can decrease the absorption of LA, the precursor of prostaglandin F2α
(PGF). Indeed, decreasing the omega-6–omega-3 ratio in the diet of dairy cattle can reduce PGF levels. These PGF reductions likely occur because LA and ALA compete for the same metabolic pathways, influencing their incorporation into cell membranes and the relative availability of fatty acid precursors for COX enzymes involved in prostaglandin synthesis.
The PGF reduction observed during decreased omega-6–omega-3 ratios has been associated with higher progesterone concentrations, which are crucial for maintaining pregnancy. Likewise, reduced PGF has also been associated with delayed corpus luteum
(CL) regression [
7,
8], which could play a role in decreasing pregnancy losses. In that sense, pregnancy losses in dairy cattle have been linked to both CL regression and embryo failure [
9]. In this context, a recent meta-analysis including nearly 20,000 pregnancy records in dairy cows reported pregnancy losses of approximately 27% before day 30, 20% between days 32–60, and 2% between 60 and 90 days post-AI [
10]. Earlier work estimated comparable stages of loss at 36%, 8%, and 2%, respectively [
11]. Regardless of the percentage, most pregnancy losses in dairy cattle occur before day 30 post-AI, followed by losses between day 32 and 60, and smaller losses from 60 to 90 days post-timed artificial insemination
(TAI).
Previous studies have demonstrated that dietary supplementation with omega-3 can increase first-service conception in primiparous and multiparous dairy cows [
12], improve early embryo development [
13] and elongation [
14], and reduce pregnancy loss [
15,
16]. The present study investigated whether altering the ratio of LA:ALA in the diet could lead to changes in pregnancy development parameters. Additionally, limited information is available regarding the effects of the dietary LA:ALA ratio on in vivo pregnancy development during the first two months of gestation. Therefore, this study aimed to evaluate the effect of the dietary LA:ALA ratio on oocyte quality and pregnancy development during the first 60 days of gestation in high-producing lactating Holstein cows. Additionally, we assessed milk production and composition. Specifically, we hypothesized that decreasing the dietary LA:ALA ratio would enhance (1) postpartum cyclicity and oocyte quality; (2) pregnancy development-related parameters during the first 60 days of gestation in Holstein cows; and (3) milk production and composition.
2. Materials and Methods
2.1. Ethics Statement
All animal procedures were conducted in accordance with the Guide for the Care and Use of Agricultural Animals in Research and Teaching (United States Department of Agriculture). The experimental protocol was approved by the Institutional Animal Care and Use Committee (IACUC) at Kansas State University on 13 August 2021, under protocol no. 4590.
2.2. Cows, Location, and Experimental Design
A total of 49 lactating Holstein cows were enrolled in the study. Eligibility required the absence of apparent reproductive tract abnormalities based on ultrasonography and no evidence of health disorders based on an automated ear-tag activity monitoring system (CowManager B.V., Harmelen, Utrecht, The Netherlands). The experiment was carried out at the Kansas State University Dairy Teaching and Research Center from December 2021 through August 2022. Cows were housed in sand-bedded free-stall barns with roofs over the beds. From May until the end of the experiment in August, heat-abatement strategies (i.e., sprinklers over the feed bunk, fans over the beds, and shades over the stall alleys) were implemented. The herd yearly average milk yield was 44.1 kg/cow per day, with milk protein and fat concentrations of 3.0 g/kg and 3.5 g/kg, respectively. Enrolled cows were milked three times daily.
Figure 1 illustrates the study’s experimental design. The study followed a randomized complete block design with parity (primiparous and multiparous) as the blocking factor. Cows were enrolled within the first three weeks after calving and assigned to one of six adjacent pens (three pens per dietary treatment). At any given time, enrollment occurred in two pens (one per diet) until pen capacity was reached, after which enrollment proceeded to the next pair of pens. Because enrollment occurred over approximately 12 weeks and cows remained in the study for ~140 days, all pens were occupied concurrently for part of the experimental period, although cows were at different study days. The two experimental diets were balanced to deliver a 6:1-LA:ALA ratio (
Low-OMG3: n = 3 pens; 11 primiparous, 14 multiparous) or a 2:1-LA:ALA ratio (
High-OMG3: n = 3 pens; 10 primiparous, 14 multiparous). The High-OMG3 diet was formulated by incorporating GreatOPlus
® into the TMR. GreatOPlus
® (
Supplementary Materials Table S1) is an extruded feed product produced by Naturally Better Omega-3 (Manhattan, KS, USA) that combines flaxseed, a source of ALA, with
Nannochloropsis oculata, a source of eicosapentaenoic acid
(EPA) [
17]. Diets were isocaloric and isonitrogenous (
Table 1), and the expected intake for the fatty acid composition of the formulated diets is shown in
Table 2. Samples of individual dietary ingredients were collected on a weekly basis throughout the experimental period and stored at −20 °C until analysis. Composite samples of all ingredients, prepared from two months of weekly collections during the eight-month study, were analyzed for nutrient composition by near-infrared reflectance spectroscopy at a commercial laboratory (Dairy One, Ithaca, NY, USA). Regardless of experimental diet, TMR was provided once daily and formulated to meet or exceed nutrient requirements for lactating Holstein cows producing 50 kg/d of milk at 3.5% fat and 3.1% true protein, with an anticipated dry matter intake of 24 kg/d [
18]. Water and salt mineral blocks were available ad libitum to all cows. Data collection for each cow continued until at least one of the following criteria was met: (1) 60 days of gestation; (2) a non-pregnant diagnosis after the second TAI; or (3) a pregnancy loss diagnosis. Cows remained in the experimental pens even if they were removed from the study.
2.3. Body Condition Score and Postpartum Cyclicity
Body condition was assessed using a 5-point scale (1 = thin; 5 = obese) with 0.25-unit increments. Assessments were performed at calving, at 21 days after calving, on the day of ovum pickup (OPU; 48 DIM), at approximately 75 and 110 DIM during first and second services, and at 30 and 60 days of gestation. All cows were evaluated via transrectal ultrasonography twice weekly between 21 and 45 ± 3 DIM to determine resumption of postpartum cyclicity based on the presence of a CL. All ultrasound examinations in the study were performed in a palpation rail using an Ibex-Evo II (E.I. Medical Imaging, Loveland, CO, USA), equipped with a multilinear-array transducer set up at 7.5 MHz.
2.4. Blood and Milk Sample Collections
Throughout the experiment, blood and milk samples were collected at 15, 50, 75, 110, and 140 ± 3 DIM. These time points correspond to the enrollment, OPU, and pregnancy check events, respectively. Blood samples were obtained via coccygeal venipuncture using evacuated tubes containing sodium heparin (Vacutainer, Becton Dickinson, and Co., Franklin Lakes, NJ, USA) and immediately placed on ice. Plasma was separated by centrifugation at 1800× g using a J-6B centrifuge (Beckman Coulter Inc., Brea, CA, USA) and stored at −20 °C until analysis. Milk samples were collected from the first milking of the day in the milking parlor using plastic sampling bottles attached directly to the milk line. Samples were gently mixed, and subsamples were transferred into two vials: one for milk component analysis and one for fatty acid analysis (stored at −20 °C until assayed).
2.5. Milk Yield, Components, and Fatty Acid Profiles in Blood and Milk
Milk yield was recorded at each milking from enrollment until removal from the study. Daily milk weights were converted from pounds to kilograms, and weekly means were calculated for statistical analysis. Milk samples collected at enrollment (used as a covariate) and at 50, 75, 110, and 140 DIM were submitted to the Dairy Herd Improvement Laboratory (MQT Lab Services, Kansas City, MO, USA) for determination of milk composition, i.e., protein [kg], fat [kg], lactose [kg], and somatic cell count.
Plasma obtained from the blood samples at enrollment, 50, 75, 110, and 140 DIM, and milk samples from enrollment and 50 DIM were used to determine fatty acid profiles in blood and milk. Briefly, milk (200 µL) and plasma (500 µL) samples were analyzed for long-chain fatty acid composition with minor modifications to the procedures described by [
17] and in the Supelco Technical Bulletin #T496125B [
19]. Samples were frozen, freeze-dried overnight, and methylated with 1 mL of benzene containing methyl-C13 internal standard (2 mg/mL) and 4 mL of boron trifluoride–methanol reagent (Supelco, Bellefonte, PA, USA; catalog #B1252). Tubes were gassed with nitrogen, capped, and incubated at 60 °C for 60 min. After cooling, 4 mL of water and 1 mL of hexane were added, vortexed, and centrifuged (1000×
g, 10 min). The upper organic layer (~1–2 mL) was collected for chromatographic analysis. Fatty acid methyl esters were separated with a capillary column (SP-2560 Supelco, Bellefonte, PA, USA; 100 m × 0.25 mm × 0.20 µm film thickness) with helium as the carrier gas at a flow rate of 1 mL/min. Injector and detector temperatures were maintained at 250 °C. The oven temperature program started at 100 °C (5 min hold), increased at 3 °C per minute to 240 °C, and was held for 20 min.
Individual fatty acid peaks were identified using the Supelco 37-component fatty acid methyl ester reference mixture (catalog #47885-U) and conjugated linoleic acid standards (Matreya, State College, PA, USA; catalog #1255, 1257, 1256, 1254). Response factors for conjugated linoleic acid isomers were derived from the linoleic acid (C18:2) peak average, and for cis-11 octadecenoic acid (C18:1 cis-11) and trans-11 octadecenoic acid (C18:1 trans-11) from cis-9 octadecenoic acid (C18:1 cis-9) and trans-9 octadecenoic acid (C18:1 trans-9), respectively. Docosapentaenoic acid (C22:5 n-3) was identified using a marine polyunsaturated fatty acid reference standard (Sigma, catalog #47033), and its concentration was estimated assuming the same detector response as docosahexaenoic acid (C22:6 n-3).
2.6. Oocyte Quality
An intramuscular dose of gonadorelin acetate (100 mcg; 1 mL GONAbreed, Parnell Technologies PTY, LTD, Alexandria, New South Wales, Australia) was administered at 45 ± 3 DIM to synchronize a follicular wave prior to a single
OPU at 48 ± 3 DIM. Briefly, cows were restrained in a chute, and the area around the first and second caudal vertebrae was clipped and disinfected. Epidural anesthesia was achieved using 3.5 mL of lidocaine administered in the intercoccygeal space. Follicles estimated to measure ≥ 3 mm in diameter were aspirated using an ultrasound-guided transvaginal approach [
20] coupled to a vacuum system operating at a continuous negative pressure of 72 mmHg and fitted with a 21-gauge needle. Follicular contents were collected into sterile 50 mL Falcon tubes containing OPU recovery medium (BoviPlus
®, Minitube, Tiefenbach, Germany) at 38 °C. The recovered fluid was diluted and filtered to facilitate oocyte identification under a stereomicroscope. Recovered oocytes were counted and morphologically evaluated, and cumulus–oocyte complexes were classified according to International Embryo Technology Society guidelines [
21] as grade 1 (compact cumulus with >3 cell layers), grade 2 (partial or <3 cumulus cell layers), grade 3 (sparse or absent cumulus cells), or degenerated (oocyte damaged).
Following recovery, oocytes from each cow were placed into cryotubes containing maturation medium and transported overnight in a portable incubator maintained at 38 °C for subsequent assessment of lipid content and mitochondrial abundance. Since handling and transport conditions can influence lipid profiles and mitochondrial activity, oocytes were placed in maturation media to help preserve viability and cellular integrity from collection to staining. These parameters were chosen to test whether omega-3 supplementation, known to alter fatty acid composition and oxidative balance, could influence oocyte energy metabolism and quality. Oocyte recovery data (number of follicles aspirated and oocyte grades) are reported for all 49 cows enrolled in the study. Analyses of oocyte mitochondrial activity and lipid content were performed on oocytes collected from cows enrolled between weeks 4 and 12 of the enrollment period, after staining and imaging protocols were fully established. This subset included cows from both dietary treatments and parities (Low-OMG3: 6 primiparous, 12 multiparous; High-OMG3: 5 primiparous, 11 multiparous) and contributed 166 evaluable oocytes (excluding degenerated oocytes). Cows enrolled during weeks 1–3 were used to establish oocyte recovery, transport, and staining logistics and were therefore not included in the fluorescence analyses. Briefly, each oocyte was sequentially stained for both mitochondria and lipids following previously reported methods [
22,
23].
Matured oocytes were stained with MitoTracker Deep Red at a 200 nM concentration (Invitrogen, Carlsbad, CA, USA) in Medium-199 supplemented with 1% sodium pyruvate and 0.1% gentamicin for 40 min at 38.5 °C. After staining, oocytes were washed three times in PBS supplemented with 0.1% PVP (PBS-PVP) and fixed in 4% paraformaldehyde for 20 min. Oocytes were then co-stained with 10 µg/mL Nile Red and 1 µg/mL Hoechst 33342 for 15 min to label lipid content and nuclei. The Nile Red working solution was prepared from a stock made by dissolving 1 mg of dye in 1 mL DMSO and diluting in PBS-PVP to 10 µg/mL. Oocytes were mounted on slides containing 10 µL of SlowFade Gold antifade reagent (Life Technologies, Carlsbad, CA, USA), covered with a coverslip, and stored at 4 °C until imaging. Individual oocytes were imaged using a Leica DM5500 epifluorescence microscope (Leica Microsystems, Wetzlar, Germany). Fluorescence quantification was performed using ImageJ v1.46r (National Institutes of Health). Background fluorescence was subtracted, and mean fluorescence intensity was measured within a defined region of interest for each oocyte. Mean intensity values were used to estimate mitochondrial activity (MitoTracker Deep Red) and lipid content (Nile Red). Fluorescence intensity was expressed as arbitrary units (AUs).
2.7. Timed Artificial Insemination and Pregnancy Development-Related Parameters
To prepare cows for first service at 75 ± 3 DIM, a synchronization protocol [
24] was initiated at 55 ± 3 DIM. The protocol consisted of 500 mcg of cloprostenol sodium, followed 3 days later by 100 mcg of gonadorelin acetate. Seven days later, an Ovsynch-56 protocol (with two 500 mcg doses of cloprostenol) was used [
25]. Pregnancy status was assessed by transrectal ultrasonography at 32 days after TAI based on the detection of an embryo with a heartbeat. Cows identified as nonpregnant were immediately assigned to one of two resynchronization strategies according to ovarian status. Cows bearing a CL were subjected to a Short-Synch protocol [
26] (day 0 [day of pregnancy diagnosis] and day 1, 500 mcg of cloprostenol sodium; day 2 [PM]: 100 mcg of gonadorelin acetate; and TAI 16 to 18 h later). Open cows lacking a CL at pregnancy diagnosis but presenting a follicle ≥ 10 mm in diameter [
27] were submitted to an Ovsynch-56. Cows were subjected to a single resynchronization event, and only first- and second-service data were included in the analyses.
Pregnancy-related measurements assessed during the second phase of the study are summarized in
Figure 1B. Starting on day 11 post-TAI, blood samples were collected weekly, regardless of service number, to determine progesterone and pregnancy-associated glycoprotein
(PAG) concentrations until pregnancy diagnosis at day 32 post-TAI. Concurrent ultrasonographic evaluations were performed to assess CL diameter and luteal blood flow using Doppler ultrasonography [
28]. Cows confirmed pregnant at day 32 post-TAI, based on detection of a viable conceptus with a heartbeat, continued to undergo weekly blood sampling from day 32 to 60 post-TAI for progesterone and PAG analyses. From day 32 through day 53 post-TAI, weekly ultrasonographic examinations were conducted to evaluate CL diameter and blood flow, as well as conceptus morphometric traits: crown–rump length, conceptus width, and amniotic vesicle length and width [
28,
29]. At day 60 post-TAI, fetal head length and width were recorded instead of whole-fetus measurements due to imaging limitations at this stage of gestation [
30]. Volumes of the CL and embryonic vesicle were calculated using the sphere volume equation [V = 4/3 × π × R
3, where R = (length/2 + width/2)/2]. At each ultrasonographic evaluation, conceptus viability was verified by assessing the heartbeat. Data collection was discontinued in cows experiencing pregnancy loss, defined as the absence of a viable conceptus.
Progesterone concentrations were quantified using a solid-phase radioimmunoassay with antibody-coated tubes and 125I-labeled progesterone (ImmuChem Coated Tube progesterone 125I RIA Kit, MP Biomedicals, Irvine, CA, USA) following the manufacturer’s instructions. Assay sensitivity was 0.07 ng/mL, the intra-assay coefficient of variation was 7.8%, and the inter-assay coefficient of variation was 8.3%. Pregnancy-associated glycoprotein concentrations were determined by ELISA (BioPRYN Flex; BioTracking LLC, Moscow, ID, USA), with minor modifications to the manufacturer’s protocol. Samples from days 18, 25, 39, 46, 53, and 60 were diluted 1:10, whereas samples from day 32 were diluted 1:20 to fit in the kit standard curve. The intra-assay coefficient of variation was 7.7% and the inter-assay coefficient of variation was 9.8%.
2.8. Statistical Analyses
A power analysis was performed, taking into account the effects of diet and using the pen as the experimental unit. The sample size calculation was designed to detect a difference in means of 2 kg of milk (46 vs. 48 kg) at a significance level of 0.05, assuming a pen-level variance of 1 (based on the number of animals per pen to reduce pen-level variance). This resulted in a requirement of three pens per treatment group to achieve a statistical power of 70%. The analysis did not account for DIM, parity, or pregnancy-related parameters. Thus, the reproductive outcomes evaluated (cyclicity, oocyte quality, CL size and blood flow, progesterone and PAG concentrations, and conceptus size) were not powered, and the study should be considered exploratory for those endpoints. This approach was chosen because the study aimed to generate effect size estimates to inform future reproductive research.
For body condition score, blood and milk fatty acid profile, milk production, and milk components (protein, fat, lactose, and somatic cell count [SCC]), the response value at the beginning of the experiment (15 DIM) was tested for differences between diets to ensure that the effect of diet did not already exist between the groups before the experiment started. The model included the fixed effects of diet, parity, and the interaction between diet-by-parity, and the random effects of pen within the diet and week of enrollment. The effect of diet was not significant for any of the response variables, and the value at the beginning of the experiment was fitted as a covariate in the model for subsequent analyses. Each response variable was analyzed in a separate model with the value at the first day of experiment as a covariate, and diet (Low-OMG3 and High-OMG3), parity (primiparous vs. multiparous), DIM (as a linear and quadratic covariate), and interactions between diet-by-parity and diet-by-DIM as fixed effects. Random effects were cow, pen within diet, and week of enrollment. Pen was the experimental unit in the experiment and accounted for by the random effect of pen within the diet. Because cows were enrolled in the study as they calved, the week in which each cow was enrolled in the study (study week 1 to 12) was also fitted as a random effect. The quadratic effect of DIM was tested for all response variables and removed from the model when not significant (p > 0.05). For milk production, DIM was replaced by weeks in milk (WIM), as milk weights were analyzed as weekly averages. Somatic cell count was log-transformed to approach normality. The pregnancy-related variables were CL volume and blood flow, progesterone and PAG concentrations, conceptus size, and vesicle volume, and the effect of DIM was substituted by the effect of days post-TAI. The quadratic effect of days post-TAI was also tested for all response variables and removed from the model when not significant (p > 0.05). For oocyte quality traits, for which there were no repeated records, the fixed effects included diet, parity, and the interaction between diet and parity, and the random effects were pen within the diet and the week of enrollment.
Multiple test comparisons were performed with Tukey’s adjustment when one of the main effects or interactions was significantly different. The normality of the residuals for each model was assessed individually using the Shapiro–Wilk test and visual inspection of the Q-Q plot. Differences were considered statistically significant at
p ≤ 0.05 and tendencies when 0.05 <
p ≤ 0.10. Results are shown as adjusted means ± standard error of the mean
(SEM) or 95% confidence interval (for the log-transformed variable). Statistical analyses were conducted using the GLIMMIX procedure in SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).
Supplementary Materials Table S2 shows the number of pens, cows, records, and mean lactation number ±SEM for the major analyses conducted in the study.
4. Discussion
Supplementation of dairy cow diets with fat is a common practice in the dairy industry to achieve greater energy density, especially during the transition period [
31]. However, commercial fat supplements used in dairy diets typically provide a greater proportion of omega-6 than omega-3 FAs. In addition, other components of the TMR diet are richer in omega-6 than omega-3 [
5], intensifying the imbalance and promoting pro-inflammatory pathways [
1]. However, previous studies have demonstrated that omega-3 FA can improve early embryo development and decrease PGF secretion, which could extend the CL lifespan. These two mechanisms are of particular interest in our study since pregnancy losses in dairy cattle have been linked to both CL and embryo failure [
9]. The present study investigated whether feeding lactating dairy cows a diet enriched in ALA as a means to increase omega-3 could lead to alterations in pregnancy development parameters. The results of the current study demonstrated that decreasing the LA:ALA ratio in the diet of lactating cows enhanced milk yield, protein, and lactose at 50 DIM, CL volume (11 to 32 days post-TAI), and CL blood flow (32 to 60 days post-TAI). However, these changes were not associated with progesterone concentrations, oocyte quality, or the pregnancy-development-related parameters evaluated in this study.
Consistent with the treatment diets, the plasma omega-6–omega-3 ratio was similar between groups at enrollment and decreased in High-OMG3 cows at 50, 75, 110, and 140 DIM. The greater omega-3 concentration obtained from plasma (
Figure 2) demonstrates that the High-OMG3 diet, which included flaxseed and algae, can provide absorbable omega-3 content that is available in circulation. Accordingly, High-OMG3 cows exhibited a lower omega-6–omega-3 ratio and greater omega-3 content as early as 50 DIM. This is consistent with previous reports showing that omega-3 fatty acids can be metabolized and deposited in milk within approximately four weeks of dietary intake [
13]. A 67% reduction in the omega-6–omega-3 ratio between 15 and 50 DIM was observed in High-OMG3 cows, consistent with the 41% reduction previously reported for rumen-protected, encapsulated fish oil supplementation [
32].
Dietary omega-3 supplementation has been associated with increased omega-3 content across multiple tissues in dairy cattle. Reductions in the omega-6–omega-3 ratio have been reported in the endometrium, liver, mammary gland, and muscle following supplementation with calcium salts of fish oil compared with whole cottonseed between 17 and 194 DIM [
33,
34]. In caruncles, fish oil supplementation has also been shown to increase omega-3 fatty acid content when compared to omega-6-rich lipid sources such as olive oil [
8]. In this context, the use of a product such as GreatOPlus
®, which combines flaxseed and
Nannochloropsis oculata, provides complementary omega-3 sources: flaxseed supplies ALA, and
Nannochloropsis oculata serves as a direct source of EPA. This distinction is biologically relevant, given the limited efficiency of endogenous ALA conversion to EPA [
35].
Given the established roles of omega-3 and omega-6 fatty acids in modulating anti-inflammatory and pro-inflammatory pathways, we hypothesized that dietary treatment would influence postpartum resumption of cyclicity and oocyte quality. However, our results failed to support the hypothesis regarding the resumption of cyclicity. This outcome aligns with previous reports indicating no differences in the proportion of cyclic cows at 63 DIM following palm oil or fish oil supplementation from 30 to 160 DIM [
16], as well as the absence of differences in the timing of first postpartum ovulation in cows supplemented with protected fish oil compared with toasted soybean [
32]. In contrast, Sinedino et al. (2017) [
12] increased estrus expression in primiparous cows fed an algae-supplemented diet relative to controls, whereas no such effect was observed in multiparous cows, highlighting potential parity-dependent responses to omega-3 supplementation. Our results also failed to support the hypothesis of oocyte quality, as no effect of diet or a diet-by-parity interaction was observed on the evaluated parameters. Within different ovarian compartments (e.g., follicular fluid, granulosa cells, cumulus-oocyte), omega-3 content has been reported to be altered [
36], suggesting a specific role or distinct metabolism of PUFAs in these tissues [
5]. This selective uptake has been associated with alterations in oocyte quality, as reported in ewes [
36] and dairy cow embryos [
13,
37]. However, our results for oocyte mitochondrial abundance and lipid content did not differ between diets and also did not support the hypothesis. One may consider that we aspirated and synchronized small, growing follicles that may have only been in contact with the follicular fluid for a short period.
The second part of our working hypothesis was primarily not supported. That is, the dietary LA:ALA ratio did not enhance in vivo pregnancy development during the first 60 days of gestation in dairy cows. Evidence partially supporting the hypothesis was observed in the larger CL volume observed between 11 and 32 days post-TAI and greater CL blood flow between 32 and 60 days post-TAI in High-OMG3 compared with Low-OMG3 cows. The larger CL observed in the High-OMG3 group in our study could be attributed to a larger preovulatory follicle [
38] during the synchronization protocol; however, we did not evaluate this parameter in our experiment. Previous studies have shown that cows supplemented with omega-3 have greater preovulatory follicle size [
15,
32], whereas others have not found differences [
12,
39]. Thus, in our study, it remains unclear whether omega-3 supplementation increased the preovulatory follicle size and, consequently, the CL size.
Despite differences in CL size observed in our study, progesterone concentrations did not differ between diets. The relationship between CL size and progesterone concentration is well established; however, in certain physiological contexts—such as when comparing non-lactating heifers and lactating cows—non-lactating heifers typically have smaller CL but greater progesterone concentrations [
40,
41]. In lactating dairy cows, elevated milk production is associated with increased feed intake and hepatic blood flow, which in turn enhances the metabolic clearance of steroid hormones such as progesterone [
42]. Consequently, circulating progesterone concentrations reflect not only corpus luteum size and function, but also the rate of systemic progesterone metabolism. Under conditions of high hepatic clearance, increases in CL size and luteal blood flow may therefore not translate into higher circulating progesterone concentrations [
40,
41,
42]. This mechanism provides a plausible explanation for the dissociation observed in the present study between greater CL size and blood flow and unchanged progesterone concentrations in High-OMG3 cows, which also exhibited greater milk yield than cows receiving the Low-OMG3 diet.
Reports on the effects of omega-3 supplementation on progesterone concentrations are contrasting in the literature. Several studies have reported no differences in progesterone concentrations when comparing omega-3- and omega-6-enriched diets in lactating dairy cows [
12,
13,
15]. However, others have documented increased progesterone concentrations in response to omega-3 supplementation [
43]. In contrast, Hutchinson et al. (2012) [
44] reported reduced CL volume and progesterone concentrations in cows fed omega-3 diets. The differences between the studies could be related to the period of supplementation, the timing of evaluating progesterone concentrations, and whether they were evaluated in pregnant and non-pregnant cows or only in one of these categories. We analyzed data from pregnant cows through day 60 of gestation, whereas other studies collected samples on non-bred cows or cows regardless of their pregnancy status [
43], or collected samples at days 0, 21, and 24 post-TAI as part of early pregnancy status assessment [
15].
We did not observe a difference in PAG concentration between diets. Maternal PAG concentrations in blood have been used as a marker of embryo presence [
9]. However, its function remains to be elucidated. At approximately 20 days of gestation in cows, binucleate giant cells originating from the trophoblast migrate to the endometrial epithelium [
45] and synthesize PAG until it is released into maternal circulation [
46]. Thus, PAG concentrations from 20 to 28 days post-TAI have been associated with pregnancy viability [
47]. Although the High-OMG3 diet resulted in a larger CL and greater blood flow during specific times within the first 60 days of gestation, the results did not provide evidence of a direct effect of omega-3 supplementation on conceptus or amniotic vesicle size during this period.
Finally, the last part of our working hypothesis was supported, since decreasing the dietary LA:ALA ratio in lactating cows increased the average milk yield during the study period. Reports on the effects of omega-3 supplementation on milk production are inconsistent in the literature. Some studies have reported no differences between omega-3 diets and control diets [
13,
15,
32,
48], while others have observed increased milk production [
12,
49,
50]. It should be noted that in some of those studies, omega-3 and control diets were not isocaloric, unlike in the present study. Contrary to our hypothesis, SCC and fat yield did not differ between diets. Additionally, differences in protein and lactose yields were only observed at 50 DIM but not at later time points. Similarly, no differences in milk protein or fat percentage were reported by Thangavelu et al. (2007) [
13] among cows supplemented with flaxseed (rich in omega-3 FA), sunflower (rich in omega-6 FA), or saturated fatty acids, with comparable findings reported for flaxseed versus sunflower supplementation by Ambrose et al. (2006) [
15]. A speculative explanation for the increased milk production in omega-3-supplemented cows may be related to reduced energy and nutrient utilization for pro-inflammatory pathways, as suggested by previous studies [
6,
51,
52].
Although dietary omega-3 supplementation increased milk production in the current study, several limitations should be considered when interpreting the reproductive outcomes reported herein. The experimental design and power analysis were based on milk yield, using pen as the experimental unit, and the study was not powered to detect small differences in reproductive endpoints; therefore, conclusions regarding cyclicity, corpus luteum characteristics, oocyte quality, and early pregnancy development should be interpreted cautiously. These results should be viewed as effect-size estimates to inform future reproductive research. Pregnancy data from first and second timed artificial inseminations were pooled to maximize available observations, which may have masked biologically relevant differences associated with service number or stage of lactation. In addition, oocyte quality was assessed following synchronization and aspiration of relatively small follicles at approximately 48 DIM, a timing that may limit the ability to detect dietary effects on oocyte competence. Mitochondrial activity and lipid content were evaluated in a subset of cows after protocol standardization, and oocytes were transported overnight under controlled conditions, which may influence absolute fluorescence measurements. Furthermore, the observed increases in corpus luteum size and blood flow without corresponding changes in circulating progesterone suggest that luteal structural or vascular changes do not necessarily translate into measurable endocrine differences, potentially due to factors such as progesterone metabolic clearance. However, the modest number of pens per treatment (n = 3) inherently limits pen-level inference and generalizability, despite appropriate statistical modeling. Collectively, these considerations support a conservative interpretation of the limited effects of omega-3 on early pregnancy development and reproductive outcomes, while reinforcing the robustness of the observed milk production response and underscoring the need for additional research before applying LA:ALA ratio modifications as a reproductive strategy in dairy herds.